Our Team

john@fcaaids.org

John joined FCAA as Executive Director in November 2009. For nearly 25 years, John Barnes has held positions of increasing responsibility in government, non-profit and corporate settings. He has established new programs and managed federally funded programs within state government, founded and directed a range of non-profit organizations and associations and managed philanthropic programs of a Fortune 100 company. John began his career working for the State of Delaware on child welfare issues. He went on to develop and implement a state-wide HIV/AIDS case management program for the Division of Public Health, where he also managed the first federal funds for HIV related services. It was in this position that John served as the Founding Board Chair of the Delaware HIV CARE Consortium, a state-wide planning body focused on HIV care and prevention.

John’s non-profit management experience includes running a variety of community-based organizations serving people with HIV/AIDS and other critical illnesses, both as an Executive Director and senior manager. Most recently, as Deputy Executive Director of Food & Friends in Washington, DC, John was responsible for leading a team of development professionals in raising the organization’s $8 million annual budget – as well as overseeing communications and program functions, including the recruitment, training and retention of 12,000+ volunteers annually and the preparation and delivery of 1 million meals per year to thousands of clients over the 5,500 mile DC metro region.

As Manager of Contributions at Altria Group, Inc., John was responsible for the company’s philanthropic programming in the areas of Hunger and Domestic Violence prevention, awarding grants nation-wide totaling over $12 million annually. Additionally, he managed the company’s $10 million disaster response fund following the terrorist attacks of September 11, 2001. John’s responsibilities at Altria also included serving as the Contributions Liaison to Government Affairs staff; advising and consulting with contributions professionals within the Altria family of companies, including Miller Brewing, Kraft Foods, Philip Morris International and Philip Morris USA; and facilitating employee involvement in the work of non-profit organizations in communities across the country and around the world.

John served on the Board of Directors of FCAA from 2005-2009. John also serves on the Board of Trustees of Broadway Cares/Equity Fights AIDS.

Contact John at FCAA’s main office in Crystal City, VA.

sarah@fcaaids.org

Sarah Hamilton comes to FCAA with more than four years of private sector consulting experience, with an emphasis in stakeholder relations, corporate communications and issues management. Currently, Sarah manages FCAA's integrated approach to programming, communications and development. She was last a Senior Associate at Rabin Strategic Partners, a leading international health public affairs firm, where she worked for both non-profit and for-private clients including Columbia University, Johnson & Johnson and the Tibotec Global Access Program. A Midwest transplant, Sarah currently lives in Pullman, Washington with her husband Zach, son Elijah and a growing number of pets.

Contact Sarah for any media, program, and development needs at FCAA’s West Coast satellite office.

Daniel Lee is Executive Director of the Levi Strauss Foundation (Chair).

He Joined Levi Strauss & Co. (LS&CO.), and the Levi Strauss Foundation in 2003 as a 
Community Affairs Manager for the Asia Pacific Division in Singapore, where he managed and implemented corporate social responsibility programs, employee volunteerism and grantmaking in three global giving areas -- HIV/AIDS, worker rights, and asset building. Subsequently, he relocated to San Francisco and assumed the role of Director of Global Grantmaking Programs. Daniel has extensive experience with international non-governmental organizations in the fields of human rights, HIV/AIDS and social justice.

Before joining LS&Co., he served as Senior Program Officer for Asia and Pacific at the International Gay and Lesbian Human Rights Commission (IGLHRC) and on the founding board of the Massachusetts Asian AIDS Prevention Project. In addition to FCAA, Daniel currently serves on the International Advisory Board of the Astraea Lesbian Foundation for Justice and the Asia-Oceania advisory panel of the Global Fund for Women. He received an AB in Religion and History from Princeton University and a Master of Divinity from Harvard University. Daniel was voted to the Board in November of 2008.

Anu Gupta, is Director, Corporate Contributions, Johnson & Johnson (Treasurer).

Anu leads strategic direction and program development efforts worldwide for the HIV/AIDS portfolio. In addition, she oversees the women and children's health portfolio. Previously, Dr. Gupta managed operations and focused on broadening philanthropic activities in the Asia Pacific region. Prior to joining Johnson & Johnson, she served as a consultant to The California Endowment. Dr. Gupta received her MD at the Yale University School of Medicine and completed her residency in internal medicine at Yale-New Haven Hospital where she was also a Robert Wood Johnson Clinical Scholar. Recently married, she lives with her husband Arnab in New York. Anu was voted to the board in October of 2006

Alicia L. Carbaugh, is Associate Director, Global Health & HIV Policy at the Henry J. Kaiser Family Foundation, a non-profit, private operating foundation.  Her work focuses on providing information, research, and analysis on the U.S. government’s role in global health and on the domestic and global HIV epidemics.  Ms. Carbaugh also works closely with the Foundation’s media partnerships on HIV in the United States, with entertainment companies and others.

Previously, Ms. Carbaugh served as a policy analyst for the Kaiser Commission on Medicaid and the Uninsured, a major initiative of the Foundation.  Her work focused on issues related to health care coverage, access to care, and financing of care for low-income and vulnerable populations.  Prior to joining the Foundation in 2003, she served as a senior account executive with Edelman, a global public relations firm, where her work focused on the development and execution of strategic communications initiatives for a range of corporate clients in the health industry.

Ms. Carbaugh holds a Master of Health Science degree in Health Policy from the Johns Hopkins University Bloomberg School of Public Health and graduated with a Bachelor of Arts degree from the College of William and Mary. Alicia was voted to the board in November 2009.

Patricia Doykos, Director of the Bristol-Myers Squibb Foundation.

In the area of HIV/AIDS, Dr. Doykos’s primary role is to mobilize lessons learned from Bristol Myers Squibb's flagship philanthropic program for HIV/AIDS in Africa, Secure the Future, to other regions of the world affected by the epidemic so that they can be replicated and inform evidence-based public health policy and investments. This involves ongoing outreach, advocacy and partnership development with major donors like the President’s Emergency Plan for AIDS Relief (PEPFAR), leading regional, national and community-based non-governmental organizations, governments, schools of public health, professional associations, and corporate philanthropy peers.

Dr. Doykos also has responsibility for global health strategy for the Foundation as a whole and for partnership development and grant making in the areas of serious mental illness in the U.S. and cancer in Europe. These initiatives address health disparities at the community health level by strengthening and integrating healthcare worker capacity (lay/professional) and community mobilization and supportive services for patients and their families.

Michael N. Joyner is Director, Positive Action, the global HIV and AIDS programme supported by ViiV Healthcare. The Positive Action programme initiatives are community-based and focus on the key populations most vulnerable to HIV disease, including girls and women, commercial sex workers, injecting drug users, the incarcerated, MSM, transgender and gay men.

Support from the Positive Action programme is based on one or more of the following criteria: delivering greater and meaningful involvement of people living with HIV, building capacity in grassroots communities, preventing HIV, tackling stigma and discrimination, and testing innovations in education, care and treatment. Michael works with partners around the globe and provides technical assistance and funding to help them meet project deliverables and milestones.

In 2009 Michael led the transition of the Positive Action programme from GlaxoSmithKline to ViiV Healthcare: the new joint venture between GlaxoSmithKline and Pfizer. In addition, he was a member of the internal team that created the founding principles for the newly established £50 million Positive Action for Children Fund.  His work at ViiV Healthcare includes collaborations with the ViiV corporate team and local operating companies to provide leadership and understanding of HIV and AIDS issues and share best practices of community engagement and support.

Prior to directing the Positive Action programme, Michael served as the architect of the HIV treatment advocacy programme for GlaxoSmithKline in the U.S.  During this tenure, he created the nationally recognized Summer Summit on HIV, which facilitated an exchange of scientific information about advances in HIV treatment between company scientists, external experts, and HIV community advocates, including treatment educators and thought leaders from US-based AIDS Service Organizations. Michael graduated from the University of North Carolina at Chapel Hill with a degree in Biology.  He has served as an Advisory Board Member for CDC’s Business Responds to AIDS/Labor Responds to AIDS Programme. Michael was voted to the Board in December 2010.